Kestra Private Wealth Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.66M Sell
8,290
-629
-7% -$130K 0.02% 616
2025
Q4
$1.84M Buy
8,919
+53
+0.6% +$10.6K 0.02% 568
2025
Q3
$1.59M Sell
8,866
-118
-1% -$20.1K 0.02% 607
2025
Q2
$1.45M Buy
8,984
+260
+3% +$41.4K 0.02% 600
2025
Q1
$1.48M Buy
8,724
+268
+3% +$46.5K 0.02% 544
2024
Q4
$1.41M Sell
8,456
-388
-4% -$66.3K 0.02% 532
2024
Q3
$1.52M Sell
8,844
-640
-7% -$106K 0.03% 492
2024
Q2
$1.46M Buy
9,484
+100
+1% +$15K 0.03% 470
2024
Q1
$1.44M Sell
9,384
-391
-4% -$59.6K 0.03% 461
2023
Q4
$1.54M Sell
9,775
-611
-6% -$87.8K 0.04% 422
2023
Q3
$1.52M Buy
10,386
+254
+3% +$38.7K 0.05% 367
2023
Q2
$1.55M Buy
10,132
+191
+2% +$29.8K 0.05% 347
2023
Q1
$1.54M Buy
9,941
+30
+0.3% +$4.71K 0.06% 317
2022
Q4
$1.53M Sell
9,911
-55
-0.6% -$8.11K 0.08% 283
2022
Q3
$1.31M Buy
9,966
+137
+1% +$19.2K 0.08% 286
2022
Q2
$1.33M Sell
9,829
-394
-4% -$54.3K 0.08% 292
2022
Q1
$1.52M Sell
10,223
-4,659
-31% -$689K 0.08% 274
2021
Q4
$2.41M Sell
14,882
-252
-2% -$40.7K 0.12% 186
2021
Q3
$2.51M Sell
15,134
-205
-1% -$35K 0.14% 164
2021
Q2
$2.65M Sell
15,339
-3,624
-19% -$599K 0.16% 143
2021
Q1
$3.04M Buy
18,963
+870
+5% +$149K 0.21% 114
2020
Q4
$3.06M Sell
18,093
-875
-5% -$142K 0.23% 110
2020
Q3
$2.96M Buy
+18,968
New +$3.1M 0.26% 94

Other funds holding FBT

Kestra Private Wealth Services's FBT Position: Q1 2026 in Review

Kestra Private Wealth Services reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 7.1% in Q1 2026, selling an estimated $130K and leaving 8,290 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #616.

Kestra Private Wealth Services first reported a position in FBT in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.06M in Q4 2020. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Kestra Private Wealth Services held 8,290 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.66M as of Q1 2026.
  • Kestra Private Wealth Services sold 629 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $130K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Kestra Private Wealth Services's portfolio in Q1 2026, its #616 holding.
  • Kestra Private Wealth Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2020 and has held it in 23 quarters since.
  • Kestra Private Wealth Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.06M in Q4 2020.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.